Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer

Abstract

OS is worse for patients with HNC treated at HLACs versus HHACs to cooperative group trials after accounting for radiotherapy protocol deviations. Institutional experience substantially influences survival in locally advanced HNC.